欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/5250/001
药品名称Taflotan sine 15 Mikrogramm/ml Augentropfen, Lösung
活性成分
    • tafluprost 15.0 µg/ml
剂型Eye drops, solution
上市许可持有人Santen Oy Niittyhaankatu 20 33720 TAMPERE Finland
参考成员国 - 产品名称Germany (DE)
2167941
互认成员国 - 产品名称
    • Denmark (DK)
      Taflotan iMulti
    • Belgium (BE)
      Saflutan 15 microgram/ml, oogdruppels, oplossing
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Austria (AT)
      Saflutan 15 Mikrogramm/ml Augentropfen, Lösung
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Taflotan
    • Finland (FI)
    • Poland (PL)
      Taflotan Multi
    • Latvia (LV)
      Taflotan 15 mikrogrami/ml acu pilieni, šķīdums
    • Lithuania (LT)
      -
    • Estonia (EE)
      TAFLOTAN
    • Hungary (HU)
      TAFLOTAN 15 mikrogramm/ml oldatos szemcsepp
    • Bulgaria (BG)
      Taflotan iMulti
    • Cyprus (CY)
    • Czechia (CZ)
      Taflotan iMulti
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
      Saflutan 15 mikrogramov/ml kapljice za oko, raztopina
    • Croatia (HR)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
许可日期2018/02/21
最近更新日期2024/05/08
药物ATC编码
    • S01EE05 tafluprost
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase